Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

New animal research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), reveals distinct metabolic adjustments to tirzepatide and semaglutide treatment ...

A new study says that people who use tirzepatide lose more weight than people who use semaglutide Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared in Billboard and ...

It was the first head-to-head comparison of the injectable GLP-1 medications semaglutide and tirzepatide, which are sold under the brand names Wegovy and Zepbound for weight loss. Roughly 750 ...

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the ...

Whether it's for trimming body fat or sculpting lean muscle, SARMs—short for Selective Androgen Receptor Modulators—have captured the attention of those serious about physical transformation.

SARMs are a class of drugs (still in the research stage) that provide an action similar to anabolic steroids, however, with a fundamental difference. Their selective action (in limited body tissues) ...

Whether it's for trimming body fat or sculpting lean muscle, SARMs—short for Selective Androgen Receptor Modulators—have captured the attention of those serious about physical transformation. Unlike ...

Eli Lilly’s diabetes and obesity therapy tirzepatide could find a use as a treatment for obstructive sleep apnoea (OSA) after hitting the mark in a pair of phase 3 trials. OSA is a prevalent ...